As of August 2025, President Donald Trump is reportedly considering downgrading marijuana's federal drug classification from Schedule I to a less restrictive category.
Trump is considering downgrading Marijuana’s drug classification

Trump reportedly considers reclassifying marijuana as less dangerous drug - Trump administration | The Guardian
Source: theguardian.com
Key Evidence
The Wall Street Journal reported on August 8-9, 2025, that President Trump is considering reclassifying marijuana to a less dangerous drug category (Schedule III).
Trump publicly mentioned this consideration at a fundraiser and golf club event in New Jersey.
CNN Politics highlighted Trump's focus on unlocking medical uses of marijuana through reclassification.
What the Evidence Shows
Multiple reputable news sources from August 2025 report that President Donald Trump is contemplating reclassifying marijuana as a less dangerous drug under federal law. Currently, marijuana is classified as a Schedule I substance, which denotes drugs with no accepted medical use and a high potential for abuse. The proposed change would move marijuana to Schedule III, which includes substances considered to have medical use and lower abuse potential. This reclassification would ease federal restrictions and potentially open the door for expanded medical research and legal use.
Key points:
The Wall Street Journal first reported the consideration, citing sources familiar with the matter.
Trump mentioned this possibility at a recent fundraiser and golf club event.
The move aligns with his stated interest in promoting medical research on marijuana.
Multiple outlets including The Guardian, Reuters, CNN Politics, and others have confirmed the reports independently.
This development reflects a significant shift in federal drug policy under the current Trump administration (inaugurated January 2025). It is important to note that this is still under consideration and not yet finalized or enacted.